Shared Decision-Making: Implementing the AFib 2getherTM Mobile App
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Patient MARS Scores
研究概览
简要总结
Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Caring for at least 3 patients aged 18 years and older
- •Have at least 3 patients with International Classification of Diseases tenth revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter
- •Have at least 3 patients with a CHA2DS2-VASc stroke risk score of 2 or more
- •Have at least 3 patients who are not on anticoagulation
- •Have at least 3 patients with upcoming appointments within the next 4 months
- •Preferred language is English
- •Atrial fibrillation diagnosis
- •Chads vasc score 2 or higher
- •Not on anticoagulants
- •No watchman or atrial appendage closure
- •Had an ambulatory care center (ACC) cardiology appointment in the past 12 months
- •Future appointment in the next 4 months with the same provider
排除标准
- •Providers who do not care for at least 3 patients aged 18 years and older
- •Have patients that do not have an ICD-10 diagnostic code consistent with AF or atrial flutter
- •Does not have patients with a CHA2DS2-VASc stroke risk score of 2 or more
- •Their patients are on anticoagulation
- •Their 3 patients do not have an upcoming visit within the next 4 months
- •Under the age of 18; patients
- •No ICD-10 diagnostic code consistent with AF or atrial flutter
- •Did not have a visit with a cardiovascular medicine specialist in the previous one year
- •Patients with a CHA2DS2-VASc score less than 2
- •Currently prescribed an anticoagulant
- •No upcoming cardiology visit in the next 3 months
- •Has a WATCHMAN device or left atrial appendage closure surgery
- •On hospice or for whom life expectancy is less than six months and patients
- •Bleeding episode or fall with injury in the last four weeks
- •Does not speak English
研究组 & 干预措施
AFib 2gether(TM) App
Patients with known Atrial Fibrillation will be assigned to download and use an app targeted at determining stroke risk and increasing knowledge of Atrial Fibrillation and stroke risk along with treatment options and will use this information to facilitate a discussion with their cardiovascular provider.
干预措施: Afib 2gether TM Mobile Application (Device)
结局指标
主要结局
Patient MARS Scores
时间窗: Immediately after visit
Patients evaluated the perceived usefulness of the AFib 2gether mobile application by taking the Mobile App Rating Scale (MARS) questionnaire. This evaluated 3 domains: functionality, aesthetics, and a star-based question. These scores are rated 1-5 with 5 being the highest (best) score.
次要结局
- Provider MARS Scores(Immediately after visit.)
- Reason Why the Patient Was Not on AC Prior to Their Appointment(Immediately after visit)
- Afib 2gether Accuracy Assessment(Immediately after visit.)
研究者
Alok Kapoor
Associate Professor
University of Massachusetts, Worcester